{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:18:34Z","timestamp":1792001914696,"version":"4.4.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1053\/j.semdp.2021.06.011","type":"journal-article","created":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T11:01:45Z","timestamp":1625310105000},"page":"131-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Molecular landscape of thymic epithelial tumors"],"prefix":"10.1053","volume":"39","author":[{"given":"Julia","family":"Prays","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Ortiz-Villal\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semdp.2021.06.011_bib0001","first-page":"1","article-title":"Molecular Analysis of Thymoma.","volume":"7","author":"Jr","year":"2012","journal-title":"PLoS One"},{"key":"10.1053\/j.semdp.2021.06.011_bib0002","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/ejcts\/ezs663","article-title":"Thymoma and the increased risk of developing extrathymic malignancies: a multicentre study","volume":"44","author":"Filosso","year":"2013","journal-title":"Eur J Cardio-Thoracic Surg"},{"key":"10.1053\/j.semdp.2021.06.011_bib0003","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.critrevonc.2016.01.012","article-title":"Thymoma and thymic carcinomas","volume":"99","author":"Scorsetti","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1053\/j.semdp.2021.06.011_bib0004","series-title":"WHO Classification of Tumours-Thoracic Tumours. 5th ed.","author":"Travis","year":"2021"},{"key":"10.1053\/j.semdp.2021.06.011_bib0005","doi-asserted-by":"crossref","first-page":"7607","DOI":"10.21037\/jtd-2019-thym-01","article-title":"Classification and staging of thymoma","volume":"12","author":"Markowiak","year":"2020","journal-title":"J Thorac Dis"},{"key":"10.1053\/j.semdp.2021.06.011_bib0006","doi-asserted-by":"crossref","first-page":"s125","DOI":"10.1097\/JTO.0000000000000297","article-title":"Histologic classification of thymoma: a practical guide for routine cases","volume":"9","author":"Den Bakker","year":"2014","journal-title":"J Thorac Oncol"},{"key":"10.1053\/j.semdp.2021.06.011_bib0007","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/jamaneurol.2016.0603","article-title":"Frequency of synaptic autoantibody accompaniments and neurological manifestations of thymoma","volume":"73","author":"Zekeridou","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1053\/j.semdp.2021.06.011_bib0008","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ccell.2018.01.003","article-title":"The Integrated genomic landscape of thymic epithelial tumors","volume":"33","author":"Radovich","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1053\/j.semdp.2021.06.011_bib0009","doi-asserted-by":"crossref","unstructured":"Liu H., Hsu W., Chen Y., Chan Y., Wu YC., HUang BC., et al. Primary thymic carcinoma. Ann Thorac Surg. Apr. 73(4):10761081. doi:10.1016\/s0003-4975(01)03607-4.","DOI":"10.1016\/S0003-4975(01)03607-4"},{"key":"10.1053\/j.semdp.2021.06.011_bib0010","series-title":"Primary thymic carcinoma and its association with dermatomyositis and pure red cell aplasia","first-page":"426","volume":"31","author":"Fong","year":"1992"},{"key":"10.1053\/j.semdp.2021.06.011_bib0011","first-page":"1","article-title":"Genome-wide genetic aberrations of thymoma using cDNA microarray based comparative genomic hybridization","volume":"15","author":"Lee","year":"2007","journal-title":"BMC Genomics"},{"key":"10.1053\/j.semdp.2021.06.011_bib0012","first-page":"46","article-title":"A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors","author":"Petrini","year":"2014","journal-title":"Nat Publ Gr"},{"key":"10.1053\/j.semdp.2021.06.011_bib0013","first-page":"3708","article-title":"Correlating genetic aberrations with World Health Organization-defined histology and stage across the spectrum of thymomas","volume":"63","author":"Inoue","year":"2003","journal-title":"Cancer Res"},{"key":"10.1053\/j.semdp.2021.06.011_bib0014","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/bjc.2015.425","article-title":"A large microRNA cluster on chromosome 19 is a transcriptional hallmark of WHO type A and AB thymomas","volume":"114","author":"Radovich","year":"2016","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1053\/j.semdp.2021.06.011_bib0015","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ccell.2018.01.003","article-title":"The integrated genomic landscape of thymic epithelial tumors","volume":"1233","author":"Radovich","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1053\/j.semdp.2021.06.011_bib0016","doi-asserted-by":"crossref","first-page":"9006","DOI":"10.1073\/pnas.0803051105","article-title":"Identification of the TFII-I family target genes in the vertebrate genome","volume":"105","author":"Chimge","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1053\/j.semdp.2021.06.011_bib0017","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.molmed.2017.04.002","article-title":"Pathophysiology of TFII-I: old guard wearing new hats.","volume":"23","author":"Roy","year":"2017","journal-title":"Trends Mol Med."},{"key":"10.1053\/j.semdp.2021.06.011_bib0018","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/j.biocel.2006.12.005","article-title":"c-Kit-A hematopoietic cell essential receptor tyrosine kinase","volume":"39","author":"Edling","year":"2007","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1053\/j.semdp.2021.06.011_bib0019","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1309\/A7M2XTMJQK0KPQER","article-title":"Overexpression of KIT (CD117) in chromophobe renal cell carcinoma and renal oncocytoma","volume":"121","author":"Pan","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2021.06.011_bib0020","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s00432-004-0545-z","article-title":"Tyrosine kinase receptor expression in thymomas","volume":"130","author":"Henley","year":"2004","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1053\/j.semdp.2021.06.011_bib0021","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1097\/JTO.0b013e3181e96e30","article-title":"Expression and mutational status of c-kit in thymic epithelial tumors","volume":"5","author":"Petrini","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1053\/j.semdp.2021.06.011_bib0022","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.lungcan.2012.05.108","article-title":"HER family receptor and ligand status in thymic carcinoma","volume":"77","author":"Weissferdt","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1053\/j.semdp.2021.06.011_bib0023","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/JTO.0b013e3181d86a30","article-title":"Epidermal growth factor receptor, c-kit, and her2\/neu immunostaining in advanced or recurrent thymic epithelial neoplasms staged according to the 2004 world health organization in patients treated with octreotide and prednisone: an eastern cooperative onc","volume":"5","author":"Aisner","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1053\/j.semdp.2021.06.011_bib0024","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.lungcan.2006.01.009","article-title":"Thymic carcinoma with epidermal growth factor receptor gene mutations","volume":"52","author":"Yamaguchi","year":"2006","journal-title":"Lung Cancer"},{"key":"10.1053\/j.semdp.2021.06.011_bib0025","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1158\/2159-8290.CD-14-1236","article-title":"Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities","volume":"5","author":"Skoulidis","year":"2015","journal-title":"Cancer Discov"},{"key":"10.1053\/j.semdp.2021.06.011_bib0026","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.lungcan.2008.03.013","article-title":"Mutational status of EGFR and KIT in thymoma and thymic carcinoma","volume":"62","author":"Yoh","year":"2008","journal-title":"Lung Cancer"},{"key":"10.1053\/j.semdp.2021.06.011_bib0027","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1365-2559.2003.01663.x","article-title":"Expression of apoptosis-related markers and HER-2\/neu in thymic epithelial tumours","volume":"43","author":"Pan","year":"2003","journal-title":"Histopathology"},{"issue":"3","key":"10.1053\/j.semdp.2021.06.011_bib0028","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.aanat.2007.05.003","article-title":"Immunohistochemical expression of vascular endothelial growth factor A (VEGF), and its receptors (VEGFR1, 2) in normal and pathologic conditions of the human thymus","volume":"190","author":"Maria","year":"2008","journal-title":"Ann Anat"},{"issue":"3","key":"10.1053\/j.semdp.2021.06.011_bib0029","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1067\/mtc.2002.124389","article-title":"Correlation Between Tumor Angiogenesis and Invasiveness in Thymic Epithelial Tumors","volume":"124","author":"Tomita","year":"2002","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"11","key":"10.1053\/j.semdp.2021.06.011_bib0030","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1007\/s005950170021","article-title":"Elevated serum vascular endothelial growth factor and basic fibroblast growth factor levels in patients with thymic epithelial neoplasms","volume":"31","author":"Sasaki","year":"2001","journal-title":"Surg Today"},{"key":"10.1053\/j.semdp.2021.06.011_bib0031","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.jtho.2018.07.094","article-title":"A phase II study of pemetrexed in patients with recurrent thymoma and thymic carcinoma","volume":"13","author":"Gbolahan","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1053\/j.semdp.2021.06.011_bib0032","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.jtho.2016.04.013","article-title":"PI3K as a potential therapeutic target in thymic epithelial tumors","volume":"11","author":"Alberobello","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1053\/j.semdp.2021.06.011_bib0033","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1097\/JTO.0b013e3181e392a8","article-title":"Insulin-like growth factor-1 receptor expression in thymic malignancies","volume":"5","author":"Girard","year":"2010","journal-title":"J Thorac Oncol"},{"issue":"20","key":"10.1053\/j.semdp.2021.06.011_bib0034","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1002\/cncr.25367","article-title":"Insulin-like growth factor-1 receptor and phosphorylated AKT-serine 473 expression in 132 resected thymomas and thymic carcinomas","volume":"15116","author":"Zucali","year":"2010","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2021.06.011_bib0035","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/S0002-9440(10)64426-4","article-title":"Chromosome 6 suffers frequent and multiple aberrations in thymoma","volume":"161","author":"Inoue","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1053\/j.semdp.2021.06.011_bib0036","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1097\/JTO.0000000000000298","article-title":"State of the art of genetic alterations in thymic epithelial tumors","volume":"9","author":"Rajan","year":"2014","journal-title":"J Thorac Oncol"},{"key":"10.1053\/j.semdp.2021.06.011_bib0037","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0002-9440(10)64536-1","article-title":"Recurrent genetic aberrations in thymoma and thymic carcinoma","volume":"157","author":"Zettl","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1053\/j.semdp.2021.06.011_bib0038","doi-asserted-by":"crossref","first-page":"6790","DOI":"10.1158\/1078-0432.CCR-09-0644","article-title":"Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas","volume":"15","author":"Girard","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semdp.2021.06.011_bib0039","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.lungcan.2014.04.008","article-title":"MicroRNA expression profiling of thymic epithelial tumors","volume":"85","author":"Ganci","year":"2014","journal-title":"Lung Cancer"},{"key":"10.1053\/j.semdp.2021.06.011_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-017-0655-2","article-title":"Thymic epithelial tumors phenotype relies on miR-145-5p epigenetic regulation","volume":"16","author":"Bellissimo","year":"2017","journal-title":"Mol Cancer"},{"key":"10.1053\/j.semdp.2021.06.011_bib0041","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.lungcan.2015.03.003","article-title":"Immunohistochemical status of PD-L1 in thymoma and thymic carcinoma","volume":"88","author":"Katsuya","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1053\/j.semdp.2021.06.011_bib0042","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40364-019-0177-8","article-title":"Immune biomarkers in thymic epithelial tumors: expression patterns, prognostic value and comparison of diagnostic tests for PD-L1","volume":"7","author":"Rouquette","year":"2019","journal-title":"Biomark Res"},{"key":"10.1053\/j.semdp.2021.06.011_bib0043","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0182665","article-title":"Expression of PD-L1 and other immunotherapeutic targets in thymic epithelial tumors","volume":"12","author":"Arbour","year":"2017","journal-title":"PLoS ONE"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257021000502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257021000502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:22:45Z","timestamp":1760037765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257021000502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0740257021000502"],"URL":"https:\/\/doi.org\/10.1053\/j.semdp.2021.06.011","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular landscape of thymic epithelial tumors","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semdp.2021.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}